Cartherics to test new product for ovarian cancer in clinical trials
A much-anticipated new treatment for ovarian cancer discovered in Melbourne is also being explored for other conditions ...
Startup Daily6d
Biotech startup Cartherics doses up on $15 million raise for cancer treatment trials
The latest funding will support the first clinical trial for CTH-401, the startup’s lead cell therapy product, to treat ovarian cancer.
Eight ANZ startups that raised at least $66.3 million this week
Australian and Kiwi startups in fields as diverse as cell therapy, wastewater treatment, and local government software raised ...
BioWorld4d
Cartherics' AU$15M series B advances CTH-401 for ovarian cancer
Immunotherapy company Cartherics Pty Ltd. raised AU$15 million (US$10.3 million) in an oversubscribed series B round that will support the first clinical trial for lead chimeric antigen receptor ...
precisionmedicineonline4d
Cartherics Raises A$15M, Plans to Evaluate NK-Based Cell Therapy in Ovarian Cancer
With help from the oversubscribed financing round, the Australian firm is eyeing early 2025 for a Phase I clinical trial of its TAG-72-targeting cell therapy.